Sequential Treatment with Regorafenib and Trifluridine/Tipiracil in Refractory Metastatic Colorectal Cancer

Background: The optimal sequencing of regorafenib and trifluridine/tipiracil (FTD/TPI) in refractory metastatic colorectal cancer (mCRC) remains uncertain, particularly in Asian populations. Methods: We retrospectively analyzed 110 patients with mCRC who sequentially received both agents between 201...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Min-Chi Cheng, Po-Huang Chen, Yu-Guang Chen, Shiue-Wei Lai, Jia-Hong Chen, Ming-Shen Dai, Ping-Ying Chang
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	MDPI AG 2026-03-01
Edice:	Life
Témata:	metastatic colorectal cancer regorafenib trifluridine/tipiracil treatment sequencing propensity score inverse probability of treatment weighting
On-line přístup:	https://www.mdpi.com/2075-1729/16/4/564
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!